Our Team

Leadership

Michael Liss MD, PhD, MAS, MBA

CEO

Dr. Michael Liss is a physician-scientist, entrepreneur, and nationally recognized leader in microbiome-based cancer innovation. With over 200 peer-reviewed publications, funding from the NIH and Department of Defense, and multiple national awards—including the NCI Cancer Clinical Investigator Team Leadership Award—Dr. Liss is a champion of collaborative, translational science. He has led multi-institutional clinical trials and holds several recent patent applications for microbiome technologies. At Oncobiomix, he drives product innovation to transform cancer detection and gut health through AI-powered microbiome diagnostics and therapeutics.

James White, PhD

CTO

James Robert White is founder and principal analyst at Resphera. He holds a PhD in Applied Mathematics and Scientific Computation from University of Maryland -- College Park.

Charles Leach MD

CMO

Charles T. Leach earned his BA in Chemistry from Point Loma University in San Diego where he participated in summer research. He subsequently received his Doctor of Medicine degree at the University of Utah in Salt Lake City. During his time in Utah, he was actively engaged in research focused on identifying the elastin gene sequence. He followed this training with a residency in Pediatrics and a fellowship in pediatric infectious diseases at the University of California Los Angeles. During his fellowship, he began his studies on herpesviruses as cofactors in AIDs patients. He obtained his first faculty position at the University of Texas Health Science Center in San Antonio where he continued his studies of infectious diseases, primarily in pediatric AIDs patients, and was an active member of the Pediatric Oncology Group (POG). He and his colleagues specifically studied the contribution of herpesviruses to the development of cancer in children with AIDs, resulting in numerous high impact papers, including in JAMA and The New England Journal of Medicine. He worked at UT Health for 25 years in the Department of Pediatrics, during which time he held numerous leadership roles, including Director of Research and Chief of the Division of Infectious Diseases. During his final years in academia, he served as Division Chief for Infectious Diseases at Children’s Hospital of San Antonio (CHOSA) as well as Professor of Pediatrics in the Baylor College of Medicine. Recently, he joined Oncobiomix as Chief Medical Officer.

Molly Doris

Research Program Manager

Molly Doris has a Bachelor of Science in Biochemistry and over a decade of research experience. Prior to joining Oncobiomix, Molly served as a Senior Research Coordinator for the Department of Urology at the University of Texas Health Science Center at San Antonio. Molly has extensive knowledge in patient recruitment, laboratory affairs, and regulatory compliance. She is committed to promoting excellence in research, safeguarding data integrity, and maintaining the highest quality standards in healthcare research. Molly’s role at Oncobiomix is to develop and implement advanced strategies to help execute innovative research projects, while ensuring all project efforts adhere to ethical standards and legal requirements.